Your browser doesn't support javascript.
loading
Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
Acharjee, Subroto; Teo, Koon K; Jacobs, Alice K; Hartigan, Pamela M; Barn, Kulpreet; Gosselin, Gilbert; Tanguay, Jean-Francois; Maron, David J; Kostuk, William J; Chaitman, Bernard R; Mancini, G B John; Spertus, John A; Dada, Marcin R; Bates, Eric R; Booth, David C; Weintraub, William S; O'Rourke, Robert A; Boden, William E.
Afiliação
  • Acharjee S; Einstein Medical Center Philadelphia, Philadelphia, PA.
  • Teo KK; Hamilton General Hospital/Master University, Hamilton, Canada.
  • Jacobs AK; Boston Medical Center, Boston, MA.
  • Hartigan PM; VA Connecticut Healthcare System, West Haven, CT.
  • Barn K; Geisinger Medical Center, Danville, PA.
  • Gosselin G; Montreal Heart Institute/Université de Montréal, Montreal, QC, Canada.
  • Tanguay JF; Montreal Heart Institute/Université de Montréal, Montreal, QC, Canada.
  • Maron DJ; Vanderbilt University Medical Center, Nashville, TN.
  • Kostuk WJ; London Health Science Centre, London, ON, Canada.
  • Chaitman BR; Saint Louis University School of Medicine, St. Louis, MT.
  • Mancini GB; Vancouver Hospital and Health Science Centre, Vancouver, BC, Canada.
  • Spertus JA; Mid America Heart Institute, Kansas City, MO.
  • Dada MR; Hartford Hosp, Hartford, CT.
  • Bates ER; University of Michigan, Ann Arbor, MI.
  • Booth DC; University of Kentucky Med Center, Lexington, KY.
  • Weintraub WS; Christiana Healthcare System and Center for Outcomes Research, Newark, DE.
  • O'Rourke RA; South Texas Veterans Health Care System-Audie Murphy Campus, San Antonio, TX.
  • Boden WE; Stratton VA Medical Center, Albany Medical College, Albany, NY. Electronic address: william.boden@va.gov.
Am Heart J ; 173: 108-17, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26920603
ABSTRACT

OBJECTIVES:

To determine whether sex-based differences exist in clinical effectiveness of percutaneous coronary intervention (PCI) when added to optimal medical therapy (OMT) in patients with stable coronary artery disease.

BACKGROUND:

A prior pre-specified unadjusted analysis from COURAGE showed that women randomized to PCI had a lower rate of death or myocardial infarction during a median 4.6-year follow-up with a trend for interaction with respect to sex.

METHODS:

We analyzed outcomes in 338 women (15%) and 1949 men (85%) randomized to PCI plus OMT versus OMT alone after adjustment for relevant baseline characteristics.

RESULTS:

There was no difference in treatment effect by sex for the primary end point (death or myocardial infarction; HR, 0.89; 95% CI, 0.77-1.03 for women and HR, 1.02, 95% CI 0.96-1.10 for men; P for interaction = .07). Although the event rate was low, a trend for interaction by sex was nonetheless noted for hospitalization for heart failure, with only women, but not men, assigned to PCI experiencing significantly fewer events as compared to their counterparts receiving OMT alone (HR, 0.59; 95% CI, 0.40-0.84, P < .001 for women and HR, 0.86; 95% CI, 0.74-1.01, P = .47 for men; P for interaction = .02). Both sexes randomized to PCI experienced significantly reduced need for subsequent revascularization (HR, 0.72; 95% CI, 0.62-0.83, P < .001 for women; HR, 0.84; 95% CI, 0.79-0.89, P < .001 for men; P for interaction = .02) with evidence of a sex-based differential treatment effect.

CONCLUSION:

In this adjusted analysis of the COURAGE trial, there were no significant differences in treatment effect on major outcomes between men and women. However, women assigned to PCI demonstrated a greater benefit as compared to men, with a reduction in heart failure hospitalization and need for future revascularization. These exploratory observations require further prospective study.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Fármacos Cardiovasculares / Medição de Risco / Intervenção Coronária Percutânea Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Am Heart J Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Fármacos Cardiovasculares / Medição de Risco / Intervenção Coronária Percutânea Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Am Heart J Ano de publicação: 2016 Tipo de documento: Article